newsfilter
← Latest News
PR Newswire·

Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva

Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage...